table of content
1 Study Coverage
1.1 Cancer Drug Therapy Product Introduction
1.2 Global Cancer Drug Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Drug Therapy Sales in US$ Million for the Year 2017-2028
1.2.2 Global Cancer Drug Therapy Sales in Volume for the Year 2017-2028
1.3 United States Cancer Drug Therapy Outlook 2017 VS 2022 VS 2028
1.3.1 United States Cancer Drug Therapy Sales in US$ Million for the Year 2017-2028
1.3.2 United States Cancer Drug Therapy Sales in Volume for the Year 2017-2028
1.4 Cancer Drug Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Cancer Drug Therapy in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Cancer Drug Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Cancer Drug Therapy Market Dynamics
1.5.1 Cancer Drug Therapy Industry Trends
1.5.2 Cancer Drug Therapy Market Drivers
1.5.3 Cancer Drug Therapy Market Challenges
1.5.4 Cancer Drug Therapy Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Cancer Drug Therapy Market Segment by Type
2.1.1 Targeted Therapy
2.1.2 Chemotherapy
2.1.3 Immunotherapy
2.2 Global Cancer Drug Therapy Market Size by Type
2.2.1 Global Cancer Drug Therapy Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Cancer Drug Therapy Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Cancer Drug Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Cancer Drug Therapy Market Size by Type
2.3.1 United States Cancer Drug Therapy Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Cancer Drug Therapy Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Cancer Drug Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Cancer Drug Therapy Market Segment by Application
3.1.1 Angiogenesis Inhibitors
3.1.2 mTOR Inhibitors
3.1.3 Monoclonal Antibodies
3.1.4 Cytokine Immunotherapy (IL-2)
3.2 Global Cancer Drug Therapy Market Size by Application
3.2.1 Global Cancer Drug Therapy Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Cancer Drug Therapy Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Cancer Drug Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Cancer Drug Therapy Market Size by Application
3.3.1 United States Cancer Drug Therapy Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Cancer Drug Therapy Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Cancer Drug Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cancer Drug Therapy Competitor Landscape by Company
4.1 Global Cancer Drug Therapy Market Size by Company
4.1.1 Top Global Cancer Drug Therapy Manufacturers Ranked by Revenue (2021)
4.1.2 Global Cancer Drug Therapy Revenue by Manufacturer (2017-2022)
4.1.3 Global Cancer Drug Therapy Sales by Manufacturer (2017-2022)
4.1.4 Global Cancer Drug Therapy Price by Manufacturer (2017-2022)
4.2 Global Cancer Drug Therapy Concentration Ratio (CR)
4.2.1 Cancer Drug Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cancer Drug Therapy in 2021
4.2.3 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Drug Therapy Manufacturing Base Distribution, Product Type
4.3.1 Global Cancer Drug Therapy Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Cancer Drug Therapy Product Type
4.3.3 Date of International Manufacturers Enter into Cancer Drug Therapy Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Drug Therapy Market Size by Company
4.5.1 Top Cancer Drug Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Drug Therapy Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Cancer Drug Therapy Sales by Players (2020, 2021 & 2022)
5 Global Cancer Drug Therapy Market Size by Region
5.1 Global Cancer Drug Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Drug Therapy Market Size in Volume by Region (2017-2028)
5.2.1 Global Cancer Drug Therapy Sales in Volume by Region: 2017-2022
5.2.2 Global Cancer Drug Therapy Sales in Volume Forecast by Region (2023-2028)
5.3 Global Cancer Drug Therapy Market Size in Value by Region (2017-2028)
5.3.1 Global Cancer Drug Therapy Sales in Value by Region: 2017-2022
5.3.2 Global Cancer Drug Therapy Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Drug Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Corporation Information
7.1.2 Amgen / Allergan Description and Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
7.1.5 Amgen / Allergan Recent Development
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporation Information
7.2.2 Argos Therapeutics Description and Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
7.2.5 Argos Therapeutics Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Corporation Information
7.3.2 AstraZeneca Description and Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AstraZeneca Cancer Drug Therapy Products Offered
7.3.5 AstraZeneca Recent Development
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Corporation Information
7.4.2 Aveo Pharmaceuticals Description and Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
7.4.5 Aveo Pharmaceuticals Recent Development
7.5 Bayer
7.5.1 Bayer Corporation Information
7.5.2 Bayer Description and Business Overview
7.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bayer Cancer Drug Therapy Products Offered
7.5.5 Bayer Recent Development
7.6 Exelixis
7.6.1 Exelixis Corporation Information
7.6.2 Exelixis Description and Business Overview
7.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Exelixis Cancer Drug Therapy Products Offered
7.6.5 Exelixis Recent Development
7.7 Incyte
7.7.1 Incyte Corporation Information
7.7.2 Incyte Description and Business Overview
7.7.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Incyte Cancer Drug Therapy Products Offered
7.7.5 Incyte Recent Development
7.8 Merck
7.8.1 Merck Corporation Information
7.8.2 Merck Description and Business Overview
7.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Cancer Drug Therapy Products Offered
7.8.5 Merck Recent Development
7.9 Roche
7.9.1 Roche Corporation Information
7.9.2 Roche Description and Business Overview
7.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Roche Cancer Drug Therapy Products Offered
7.9.5 Roche Recent Development
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporation Information
7.10.2 Bristol-Myers Squibb Description and Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
7.10.5 Bristol-Myers Squibb Recent Development
7.11 Eisai
7.11.1 Eisai Corporation Information
7.11.2 Eisai Description and Business Overview
7.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Eisai Cancer Drug Therapy Products Offered
7.11.5 Eisai Recent Development
7.12 Exelixis
7.12.1 Exelixis Corporation Information
7.12.2 Exelixis Description and Business Overview
7.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Exelixis Products Offered
7.12.5 Exelixis Recent Development
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Corporation Information
7.13.2 Genentech (Roche) Description and Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Genentech (Roche) Products Offered
7.13.5 Genentech (Roche) Recent Development
7.14 Novartis
7.14.1 Novartis Corporation Information
7.14.2 Novartis Description and Business Overview
7.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Novartis Products Offered
7.14.5 Novartis Recent Development
7.15 Pfizer
7.15.1 Pfizer Corporation Information
7.15.2 Pfizer Description and Business Overview
7.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Pfizer Products Offered
7.15.5 Pfizer Recent Development
7.16 Prometheus Labs
7.16.1 Prometheus Labs Corporation Information
7.16.2 Prometheus Labs Description and Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Prometheus Labs Products Offered
7.16.5 Prometheus Labs Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Cancer Drug Therapy Industry Chain Analysis
8.2 Cancer Drug Therapy Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Cancer Drug Therapy Distributors
8.3 Cancer Drug Therapy Production Mode & Process
8.4 Cancer Drug Therapy Sales and Marketing
8.4.1 Cancer Drug Therapy Sales Channels
8.4.2 Cancer Drug Therapy Distributors
8.5 Cancer Drug Therapy Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
